Abstract:What's new? Cancer‐associated fibroblasts (CAFs) contribute to the progression of lung cancer. Four and a half LIM domain protein‐2 (FHL2) is a component of focal adhesion structures. Here, the authors show that FHL2 is highly expressed in myofibroblasts in lung cancer tissue, and that FHL2 expressed by CAFs promotes proliferation and migration. FHL2 expression in CAFs also promotes the migration and invasion of cancer cells and angiogenesis in vitro, and metastatic dissemination in vivo. The findings suggest that FHL2 expression by CAFs enhances the progression of lung adenocarcinoma by promoting angiogenesis and metastasis. Cancer‐associated fibroblasts (CAFs) contribute to the progression of lung cancer. Four and a half LIM domain protein‐2 (FHL2) is a component of focal adhesion structures. We analyzed the function of FHL2 expressed by CAFs in lung adenocarcinoma. Expression of FHL2 in fibroblast subtypes was investigated using database of single‐cell RNA‐sequencing of lung cancer tissue. The role of FHL2 in the proliferation and migration of CAFs was assessed. The effects of FHL2 knockout on the migration and invasion of human lung adenocarcinoma cells and tube formation of endothelial cells induced by CAF‐conditioned medium (CM) were evaluated. The effect of FHL2 knockout in CAFs on metastasis was determined using a murine orthotopic lung cancer model. The prognostic significance of stromal FHL2 was assessed by immunohistochemistry in human adenocarcinoma specimens. FHL2 is highly expressed in myofibroblasts in cancer tissue. TGF‐β1 upregulated FHL2 expression in CAFs and FHL2 knockdown attenuated CAF proliferation. FHL2 knockout reduced CAF induced migration of A110L and H23 human lung adenocarcinoma cell lines, and the induction of tube formation of endothelial cells. FHL2 knockout reduced CAF‐induced metastasis of lung adenocarcinomas in an orthotopic model in vivo. The concentration of Osteopontin (OPN) in CM from CAF was downregulated by FHL2 knockout. siRNA silencing and antibody blocking of OPN reduced the pro‐migratory effect of CM from CAF on lung cancer cells. In resected lung adenocarcinoma specimens, positive stromal FHL2 expression was significantly associated with higher microvascular density and worse prognosis. In conclusion, FHL2 expression by CAFs enhances the progression of lung adenocarcinoma by promoting angiogenesis and metastasis.

Four-and-a-half LIM Protein 2 Promotes Invasive Potential and Epithelial-Mesenchymal Transition in Colon Cancer.

Four and a Half LIM Protein 2 (FHL2) Negatively Regulates the Transcription of E-cadherin Through Interaction with Snail1.

Four and a Half LIM Domains Protein 1 Can Be As a Double-Edged Sword in Cancer Progression

The Four-and-a-half-lim Protein 2 (FHL2) is Overexpressed in Gliomas and Associated with Oncogenic Activities.

FHL2 activates β-catenin/Wnt signaling by complexing with APC and TRIM63 in lung adenocarcinoma

Four and a Half LIM Domains 2 Contributes to the Development of Human Tongue Squamous Cell Carcinoma

Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway.

Four and a Half LIM Domains 2 (FHL2) Contribute to the Epithelial Ovarian Cancer Carcinogenesis

Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-β–like signaling pathway

Suppression of FHL2 Expression Induces Cell Differentiation and Inhibits Gastric and Colon Carcinogenesis

Krüppel-like Factor 8 Induces Epithelial-to-mesenchymal Transition and Promotes Invasion of Pancreatic Cancer Cells Through Transcriptional Activation of Four and a Half LIM-only Protein 2

The Four and a Half LIM Domains 2 (FHL2) Regulates Ovarian Granulosa Cell Tumor Progression Via Controlling AKT1 Transcription

Synergistic repression of estrogen receptor transcriptional activity by FHL2 and Smad4 in breast cancer cells.

FHL2 Antagonizes Id1-Promoted Proliferation and Invasive Capacity of Human MCF-7 Breast Cancer Cells

Fhl1 Interacts With Oestrogen Receptors And Regulates Breast Cancer Cell Growth

Role of four and a half LIM domain protein 1 in tumors (Review)

FHL2 expression by cancer‐associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma

Four-and-a-half-LIM protein 1 down-regulates estrogen receptor α activity through repression of AKT phosphorylation in human breast cancer cell.

FHL3 promotes pancreatic cancer invasion and metastasis through preventing the ubiquitination degradation of EMT associated transcription factors

FHL1 Inhibits the Progression of Colorectal Cancer by Regulating the Wnt/β-Catenin Signaling Pathway

FHL Family and Tumor